WIBP‐CorV – Sinopharm‐Wuhan vs placebo
Systemic reactogenicity events
WIBP‐CorV – Sinopharm‐Wuhan showed no clear difference in systemic reactogenicity eventse compared with placebo (high certainty).
1 finding from 1 review
- RR 0.99 [0.95, 1.03]2 studies · 27029 participantsHigh